Corbus Pharmaceuticals Holdings (CRBP) Accumulated Expenses (2013 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) reported Accumulated Expenses of $16.84 million for Q4 2025, up 210.4% from $5.43 million a year earlier and up 33.9% from the prior quarter.
Powered by 
Analysis
Corbus Pharmaceuticals Holdings (CRBP) Accumulated Expenses (2013 - 2025) Analysis & Trends
Dating back to Q4 2013, Corbus Pharmaceuticals Holdings' Accumulated Expenses record includes 47 quarters.
- Accumulated Expenses has a five-year compound annual growth rate of -5.2% (FY2020 to FY2025).
- By year, Accumulated Expenses came in at $5.43 million in FY2024 (-50.8%), $11.03 million in FY2023 (+83.9%), $6 million in FY2022 (-40.6%) and $10.09 million in FY2021 (-54.1%).
- The Q4 2025 figure ranks as the highest quarterly Accumulated Expenses since Q1 2021.
- Year over year, Accumulated Expenses gained in four of the last eight quarters, with growth averaging 34.3%.
- The high point for year-over-year Accumulated Expenses in five years was Q4 2025 (growth of 210.4%); the low point was Q1 2022 (a decline of 69.0%).
- Per Business Quant data, the three quarters before Q4 2025 came in at $12.58 million (Q3 2025), $7.65 million (Q2 2025) and $5.9 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn |
| 10 | Corbus Pharmaceuticals Holdings | 51.77 Mn | -464.86 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 16.84 Mn |
| Sep 30, 2025 | 12.58 Mn |
| Jun 30, 2025 | 7.65 Mn |
| Mar 31, 2025 | 5.90 Mn |
| Dec 31, 2024 | 5.43 Mn |
| Sep 30, 2024 | 7.18 Mn |
| Jun 30, 2024 | 10.49 Mn |
| Mar 31, 2024 | 9.40 Mn |
| Dec 31, 2023 | 11.03 Mn |
| Sep 30, 2023 | 7.55 Mn |
| Jun 30, 2023 | 6.42 Mn |
| Mar 31, 2023 | 6.47 Mn |
| Dec 31, 2022 | 6.00 Mn |
| Sep 30, 2022 | 4.83 Mn |
| Jun 30, 2022 | 4.72 Mn |
| Mar 31, 2022 | 5.50 Mn |
| Dec 31, 2021 | 10.09 Mn |
| Sep 30, 2021 | 13.37 Mn |
| Jun 30, 2021 | 15.09 Mn |
| Mar 31, 2021 | 17.74 Mn |
API Access
Corbus Pharmaceuticals Holdings Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=CRBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "CRBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=CRBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();